HUTCHMED (China) Ltd: Form 20-F for the period ended Dec 31, 2017
Filed with the SEC on Mar 12, 2018 and accepted by EDGAR at Mar 12, 2018, 06:25 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2017-01-01 to 2017-12-31 | $169.8m | us-gaap:CostOfGoodsSold |
| Research and development | 12 months2017-01-01 to 2017-12-31 | $75.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2017-01-01 to 2017-12-31 | −$53.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2017-01-01 to 2017-12-31 | $1.5m | us-gaap:InterestExpense |
| Income tax | 12 months2017-01-01 to 2017-12-31 | $3.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2017-01-01 to 2017-12-31 | −$26.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2017-01-01 to 2017-12-31 | −$0.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2017-01-01 to 2017-12-31 | −$0.43 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2017-01-01 to 2017-12-31 | 61,717,171 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2017-01-01 to 2017-12-31 | −$8.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2017-01-01 to 2017-12-31 | $5.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2017-01-01 to 2017-12-31 | $1.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-12-31 | $85.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $432.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $597.9m | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $104.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $113.0m | us-gaap:Liabilities |
| Long-term debt | At period end2017-12-31 | $30.0m | us-gaap:LongTermDebt |
| Current portion of debt | At period end2017-12-31 | $30.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-12-31 | $461.7m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2017-12-31 | 66,447,037 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001047469-18-001485. Last ingested by Listed: Nov 2, 2026, 06:07 ET. Listed shows no prices and gives no investment advice.